Wednesday, November 28, 2018 8:27:38 PM
Les has not addressed any of the very legitimate issues which I posted very clearly, imo. BTW I know he read my post because somebody emailed it to him and he responded to that email. The points that Les should answer are as follows. The issues Les cited are I bogus and meaningless non-issues.
1. how many options are left ungranted in the 20% pool?
2. Why haven't you saved any in the pool and furthermore why are you immediately giving these new ones out instead of keeping any in the pool in case you need to make any new high level hires?
3. What % of granted options have gone to Linda this year and how does she deserve to be granted options for nearly 20% of the company at this time?
4. Linda was originally granted options for 5% of the company in a hiring agreement in 2011. Those expired in June and in the meantime since that grant, all equity that existed in late 2015 has been squeezed by 94% $4 t0 0.25). So explain to us how Linda deserve to have her expiring options replaced at all, let alone have her options increased to almost 18% of the total equity of the company with all the grants she has been given this year? How was shareholders interest taken into consideration in giving Linda almost 20% of all equity in the company at this time out of our pockets, in light of what can only be described as a total financial failure?
1. how many options are left ungranted in the 20% pool?
2. Why haven't you saved any in the pool and furthermore why are you immediately giving these new ones out instead of keeping any in the pool in case you need to make any new high level hires?
3. What % of granted options have gone to Linda this year and how does she deserve to be granted options for nearly 20% of the company at this time?
4. Linda was originally granted options for 5% of the company in a hiring agreement in 2011. Those expired in June and in the meantime since that grant, all equity that existed in late 2015 has been squeezed by 94% $4 t0 0.25). So explain to us how Linda deserve to have her expiring options replaced at all, let alone have her options increased to almost 18% of the total equity of the company with all the grants she has been given this year? How was shareholders interest taken into consideration in giving Linda almost 20% of all equity in the company at this time out of our pockets, in light of what can only be described as a total financial failure?
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
